Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-02 · accession 0001209191-23-052028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-04 | 2023-10-02 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $112.68 | -1,437 | 4,894 | -23% | -$161.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-02 | S | D | 1,437 | $112.68 | 4,894 | D | — | — | (F2) Includes an aggregate of 139 shares purchased on August 31, 2023 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. |